Carol Reid

1.2k total citations
25 papers, 779 citations indexed

About

Carol Reid is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Carol Reid has authored 25 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Carol Reid's work include Muscle Physiology and Disorders (4 papers), Simulation-Based Education in Healthcare (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Carol Reid is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Simulation-Based Education in Healthcare (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Carol Reid collaborates with scholars based in United Kingdom, United States and Switzerland. Carol Reid's co-authors include Michael Ahern, Michael Jones, Tom P. Gordon, Peter Brooks, Thomas Blaettler, Dragana Bugarski‐Kirola, George Garibaldi, Armando Gabrielli, Ariane L. Herrick and Nihad Tamimi and has published in prestigious journals such as Neurology, Annals of Neurology and Biological Psychiatry.

In The Last Decade

Carol Reid

23 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Reid United Kingdom 11 295 165 131 110 99 25 779
Kristin Brown‐Gentry United States 14 548 1.9× 32 0.2× 118 0.9× 89 0.8× 13 0.1× 26 1.4k
Jeffery L. Painter United States 10 525 1.8× 20 0.1× 70 0.5× 64 0.6× 29 0.3× 28 1.3k
R Thomas Lumbers United Kingdom 17 481 1.6× 27 0.2× 153 1.2× 37 0.3× 17 0.2× 30 1.3k
Shashi Amur United States 17 221 0.7× 46 0.3× 85 0.6× 88 0.8× 35 0.4× 25 999
Yuki Bradford United States 17 331 1.1× 14 0.1× 71 0.5× 51 0.5× 47 0.5× 38 1.4k
Lisa A. Bastarache United States 9 309 1.0× 19 0.1× 92 0.7× 57 0.5× 14 0.1× 11 954
Sharon L.R. Kardia United States 19 497 1.7× 31 0.2× 214 1.6× 22 0.2× 37 0.4× 49 1.3k
Jinnan Li China 14 73 0.2× 30 0.2× 72 0.5× 11 0.1× 49 0.5× 55 947
Jeremy Hammond Australia 15 261 0.9× 163 1.0× 139 1.1× 94 0.9× 18 0.2× 30 1.1k
Richard Charnigo United States 18 157 0.5× 25 0.2× 351 2.7× 13 0.1× 47 0.5× 46 1.3k

Countries citing papers authored by Carol Reid

Since Specialization
Citations

This map shows the geographic impact of Carol Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Reid more than expected).

Fields of papers citing papers by Carol Reid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Reid. The network helps show where Carol Reid may publish in the future.

Co-authorship network of co-authors of Carol Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Reid. A scholar is included among the top collaborators of Carol Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Reid. Carol Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaidman, Craig M., Crystal M. Proud, Craig M. McDonald, et al.. (2023). Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1‐Year Interim Results from Study SRP‐9001‐103 (ENDEAVOR). Annals of Neurology. 94(5). 955–968. 47 indexed citations
2.
Zaidman, Craig M., Crystal M. Proud, Craig M. McDonald, et al.. (2023). One-year Data from ENDEAVOR, a Phase 1b Trial of Delandistrogene Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD) (S48.003). Neurology. 100(17_supplement_2). 2 indexed citations
3.
Muntoni, Francesco, Enrico Bertini, Giacomo P. Comi, et al.. (2020). Long-term follow-up of patients with type 2 and non-ambulant type 3 spinal muscular atrophy (SMA) treated with olesoxime in the OLEOS trial. Neuromuscular Disorders. 30(12). 959–969. 18 indexed citations
4.
Reid, Carol, et al.. (2020). High-Fidelity Simulation and Clinical Judgment of Nursing Students in a Maternal–Newborn Course. Western Journal of Nursing Research. 42(10). 829–837. 26 indexed citations
5.
6.
Muntoni, Francesco, Beatrice Berti, Éric Dessaud, et al.. (2017). Olesoxime in patients with type 2 or non-ambulatory type 3 Spinal muscular atrophy: a placebo-controlled phase 2 trial including a long-term, open-label follow-up study. Neuromuscular Disorders. 27. S209–S210. 1 indexed citations
7.
Bugarski‐Kirola, Dragana, Thomas Blaettler, Celso Arango, et al.. (2016). Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies. Biological Psychiatry. 82(1). 8–16. 109 indexed citations
8.
9.
Reid, Carol, et al.. (2015). Using Simulation to Teach About Poverty in Nursing Education: A Review of Available Tools. Journal of Professional Nursing. 32(2). 130–140. 28 indexed citations
10.
Chuang‐Stein, Christy, et al.. (2014). Subgroup analyses in cost‐effectiveness analyses to support health technology assessments. Pharmaceutical Statistics. 13(4). 265–274. 3 indexed citations
11.
Chuang‐Stein, Christy, et al.. (2011). Subgroup analyses of clinical effectiveness to support health technology assessments. Pharmaceutical Statistics. 10(6). 532–538. 13 indexed citations
12.
Herrick, Ariane L., F.H.J. van den Hoogen, Armando Gabrielli, et al.. (2011). Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis & Rheumatism. 63(3). 775–782. 71 indexed citations
13.
Nicholson, Brian D, et al.. (2011). Primary Care for Asylum Seekers. InnovAiT Education and inspiration for general practice. 5(2). 112–121. 1 indexed citations
14.
Reid, Carol. (2008). Collection Development in a Small Library. Digital Commons - George Fox University (George Fox University). 51(2).
15.
Rawstron, Andy C., Elena Jones, Carol Reid, et al.. (2007). Outreach monitoring service for patients with indolent B‐cell and plasma cell disorders: a UK experience. British Journal of Haematology. 139(5). 845–848. 12 indexed citations
16.
Reid, Carol, et al.. (1993). Knowledge-based searching with TOPIC®. Text REtrieval Conference. 209–221. 3 indexed citations
17.
Veiga, Rafael & Carol Reid. (1989). Investigational drugs for treatment use: an avenue of hope for minority populations.. PubMed. 81(5). 507–12. 1 indexed citations
18.
Reid, Carol, et al.. (1988). The usefulness of monographic proceedings.. PubMed. 76(1). 14–21. 2 indexed citations
19.
Ahern, Michael, et al.. (1987). DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT. Australian and New Zealand Journal of Medicine. 17(3). 301–304. 208 indexed citations
20.
Reid, Carol, et al.. (1983). Indexing consistency in MEDLINE.. PubMed. 71(2). 176–83. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin Brown‐Gentry Breakdown of academic impact, for papers by Jeffery L. Painter Breakdown of academic impact, for papers by R Thomas Lumbers Breakdown of academic impact, for papers by Shashi Amur Breakdown of academic impact, for papers by Yuki Bradford Breakdown of academic impact, for papers by Lisa A. Bastarache Breakdown of academic impact, for papers by Sharon L.R. Kardia Breakdown of academic impact, for papers by Jinnan Li Breakdown of academic impact, for papers by Jeremy Hammond Breakdown of academic impact, for papers by Richard Charnigo
Rankless by CCL
2026